99 related articles for article (PubMed ID: 29477972)
1. Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis.
Kos O; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Khatri I; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Waelli T; Yu K; Zähringer U; Gorczynski RM
Int Immunopharmacol; 2018 Apr; 57():112-120. PubMed ID: 29477972
[TBL] [Abstract][Full Text] [Related]
2. Analysis of cytokine immune response profile in response to inflammatory stimuli in mice with genetic defects in fetal and adult hemoglobin chain expression.
Khatri I; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Mach JP; Mazzoli V; Rietschel E; Terskikh A; Ulmer A; Yu K; Zähringer U; Gorczynski R
Pharmacogenomics J; 2018 Jul; 18(4):546-555. PubMed ID: 29302041
[TBL] [Abstract][Full Text] [Related]
3. An altered REDOX environment, assisted by over-expression of fetal hemoglobins, protects from inflammatory colitis and reduces inflammatory cytokine expression.
Gorczynski RM; Alexander C; Brandenburg K; Chen Z; Heini A; Neumann D; Mach JP; Rietschel ET; Tersikh A; Ulmer AJ; Yu K; Zahringer U; Khatri I
Int Immunopharmacol; 2017 Sep; 50():69-76. PubMed ID: 28641125
[TBL] [Abstract][Full Text] [Related]
4. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of WIN-34B on osteogenesis and osteoclastogenesis in cytokine-induced mesenchymal stem cells and bone marrow cells.
Seo BK; Ryu HK; Park YC; Huh JE; Baek YH
J Ethnopharmacol; 2016 Dec; 193():227-236. PubMed ID: 27401292
[TBL] [Abstract][Full Text] [Related]
7. Production of IL-7 is increased in ovariectomized mice, but not RANKL mRNA expression by osteoblasts/stromal cells in bone, and IL-7 enhances generation of osteoclast precursors in vitro.
Sato T; Watanabe K; Masuhara M; Hada N; Hakeda Y
J Bone Miner Metab; 2007; 25(1):19-27. PubMed ID: 17187190
[TBL] [Abstract][Full Text] [Related]
8. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
9. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
10. TLE3, transducing-like enhancer of split 3, suppresses osteoblast differentiation of bone marrow stromal cells.
Kokabu S; Nguyen T; Ohte S; Sato T; Katagiri T; Yoda T; Rosen V
Biochem Biophys Res Commun; 2013 Aug; 438(1):205-10. PubMed ID: 23880346
[TBL] [Abstract][Full Text] [Related]
11. Transplantation of mesenchymal stem cells ameliorates secondary osteoporosis through interleukin-17-impaired functions of recipient bone marrow mesenchymal stem cells in MRL/lpr mice.
Ma L; Aijima R; Hoshino Y; Yamaza H; Tomoda E; Tanaka Y; Sonoda S; Song G; Zhao W; Nonaka K; Shi S; Yamaza T
Stem Cell Res Ther; 2015 May; 6(1):104. PubMed ID: 26012584
[TBL] [Abstract][Full Text] [Related]
12. Effects of spinal cord injury on osteoblastogenesis, osteoclastogenesis and gene expression profiling in osteoblasts in young rats.
Jiang SD; Jiang LS; Dai LY
Osteoporos Int; 2007 Mar; 18(3):339-49. PubMed ID: 17036173
[TBL] [Abstract][Full Text] [Related]
13. Telomerase-deficient mice exhibit bone loss owing to defects in osteoblasts and increased osteoclastogenesis by inflammatory microenvironment.
Saeed H; Abdallah BM; Ditzel N; Catala-Lehnen P; Qiu W; Amling M; Kassem M
J Bone Miner Res; 2011 Jul; 26(7):1494-505. PubMed ID: 21308778
[TBL] [Abstract][Full Text] [Related]
14. The systemic bone protective effects of Gushukang granules in ovariectomized mice by inhibiting osteoclastogenesis and stimulating osteoblastogenesis.
Wang Q; Zhao Y; Sha N; Zhang Y; Li C; Zhang H; Tang D; Lu S; Shi Q; Wang Y; Shu B; Zhao D
J Pharmacol Sci; 2018 Mar; 136(3):155-164. PubMed ID: 29501580
[TBL] [Abstract][Full Text] [Related]
15. Early osteoinductive human bone marrow mesenchymal stromal/stem cells support an enhanced hematopoietic cell expansion with altered chemotaxis- and adhesion-related gene expression profiles.
Sugino N; Miura Y; Yao H; Iwasa M; Fujishiro A; Fujii S; Hirai H; Takaori-Kondo A; Ichinohe T; Maekawa T
Biochem Biophys Res Commun; 2016 Jan; 469(4):823-9. PubMed ID: 26707642
[TBL] [Abstract][Full Text] [Related]
16. Icariin influences adipogenic differentiation of stem cells affected by osteoblast-osteoclast co-culture and clinical research adipogenic.
Zhang S; Feng P; Mo G; Li D; Li Y; Mo L; Yang Z; Liang D
Biomed Pharmacother; 2017 Apr; 88():436-442. PubMed ID: 28122309
[TBL] [Abstract][Full Text] [Related]
17. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
18. Decreased osteoclastogenesis, osteoblastogenesis and low bone mass in a mouse model of type 2 diabetes.
Xu F; Dong Y; Huang X; Li M; Qin L; Ren Y; Guo F; Chen A; Huang S
Mol Med Rep; 2014 Oct; 10(4):1935-41. PubMed ID: 25109926
[TBL] [Abstract][Full Text] [Related]
19. Effects of Osteoglycin (OGN) on treating senile osteoporosis by regulating MSCs.
Chen X; Chen J; Xu D; Zhao S; Song H; Peng Y
BMC Musculoskelet Disord; 2017 Oct; 18(1):423. PubMed ID: 29073887
[TBL] [Abstract][Full Text] [Related]
20. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
